FAF
BIO icon

Fjarde Ap-fonden’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fjarde Ap-fonden’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,680
Closed -$896K – 498
2025
Q1 		$896K Buy
3,680
+200
+6% +$60.2K 0.01% 502
2024
Q4 		$1.14M Buy
3,480
+1,200
+53% +$407K 0.01% 507
2024
Q3 		$763K Buy
+2,280
New +$724K 0.01% 507
2024
Q1 		$1.35M Sell
3,900
-300
-7% -$98.7K 0.01% 513
2023
Q4 		$1.36M Buy
4,200
+100
+2% +$31.3K 0.02% 508
2023
Q3 		$1.47M Buy
4,100
+3,300
+413% +$1.27M 0.02% 509
2023
Q2 		$303K Hold
800
– – ﹤0.01% 527
2023
Q1 		$383K Buy
+800
New +$374K 0.01% 523
2022
Q4 		– Sell
-3,147
Closed -$1.56M – 520
2022
Q3 		$1.56M Hold
3,147
– – 0.02% 519
2022
Q2 		$1.56M Sell
3,147
-2,200
-41% -$1.15M 0.02% 519
2022
Q1 		$3.01M Sell
5,347
-1,003
-16% -$605K 0.03% 487
2021
Q4 		$4.8M Sell
6,350
-250
-4% -$187K 0.04% 409
2021
Q3 		$4.92M Sell
6,600
-300
-4% -$225K 0.05% 403
2021
Q2 		$4.45M Sell
6,900
-200
-3% -$122K 0.04% 445
2021
Q1 		$4.05M Buy
7,100
+600
+9% +$355K 0.04% 451
2020
Q4 		$3.79M Sell
6,500
-1,500
-19% -$854K 0.04% 453
2020
Q3 		$4.12M Hold
8,000
– – 0.04% 397
2020
Q2 		$3.61M Sell
8,000
-600
-7% -$265K 0.05% 401
2020
Q1 		$3.02M Buy
8,600
+1,500
+21% +$552K 0.05% 378
2019
Q4 		$2.63M Buy
+7,100
New +$2.5M 0.03% 511

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Fjarde Ap-fonden's BIO Position: Q2 2025 in Review

Fjarde Ap-fonden sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 3,680 shares — an estimated $896K sold.

Fjarde Ap-fonden first reported a position in BIO in Q4 2019 and held it in 20 quarters. The position peaked at $4.92M in Q3 2021. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Fjarde Ap-fonden reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Fjarde Ap-fonden sold 3,680 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $896K.
  • Fjarde Ap-fonden first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 20 quarters.
  • Fjarde Ap-fonden's Bio-Rad Laboratories Class A position peaked at $4.92M in Q3 2021.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Fjarde Ap-fonden's 13F filing for Q2 2025, filed 1 Aug 2025.